Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
08/2005
08/25/2005US20050186176 Compounds and compositions for delivering active agents
08/25/2005US20050184287 Hole transport materials; useful in making charge transport layers; organic light-emitting diodes, photovoltaic cells, light sensors, thin film organic transistors; film forming ability, solubility, thermal stability; reduced solubility when used in forming multiple layers in a device
08/25/2005CA2553442A1 Compounds and compositions as lxr modulators
08/24/2005EP1566375A1 Process for the preparation of amino acid esters and their acid addition salts
08/24/2005EP1565433A2 Novel ligands that are antagonists of rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
08/24/2005EP1565192A2 Method and compositions for temporarily incapaciting subjets
08/24/2005EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
08/24/2005EP1289930B1 Method for producing 5-aminosalicyclic acid
08/24/2005CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
08/24/2005CN1658936A Apparatus and process used in growing crystals
08/24/2005CN1657552A Comonomer compsns. of prodn. of imide-contg. polyamino acids
08/24/2005CN1216038C Novel dicarboxylic acid derivatives
08/24/2005CN1216037C Process for preparing 3-hydroxy-3-methyltutyate (HMB) amino acid salt
08/23/2005US6933352 Amphiphilic compounds having a dendritic branch structure
08/23/2005US6933101 Fluorine compound, surfactant, aqueous coating composition and silver halide photographic light-sensitive material using them
08/23/2005CA2469592C Hiv integrase inhibitors
08/19/2005CA2489743A1 Process for preparing amino acid esters and their acid addition salts
08/18/2005WO2005075501A1 Polyoxyalkylene compound and method for making
08/18/2005WO2005060569A3 Tame based chelators and uses thereof
08/18/2005US20050182272 Method for producing 3-amino-4,4,4-trifluorocrotonic acid esters
08/18/2005US20050182253 N,N,N',N'-tetrakis(2-quinolylmethyl)ethylenediamine; reacting with Zinc ions; inhibition of photoinduced electron transfer (PET)
08/17/2005EP1562903A2 Mucin synthesis inhibitors
08/17/2005EP1087943B1 Therapeutic biaryl derivatives
08/17/2005CN1656065A Ligand as the RAR receptor inhibitor
08/17/2005CN1215045C Stable salts of novel derivatives of 3, 3-diphenylpropylamines
08/16/2005US6930200 Mono-and di-substituted alpha-amino acid derivatives useful as raw materials for pharmaceutical and agro-chemical products
08/16/2005US6930112 Administering antagonist for n-methylaspartic acid or gamma-aminobutyric acid
08/16/2005US6930106 Inhibitors of HCV NS5B polymerase
08/16/2005US6929685 Alkylamine derivatives as antifouling agents
08/16/2005CA2117736C Process for the preparation of 5-fluoroanthranilic alkyl esters and/or 5-fluoroanthranilic acid
08/11/2005WO2005073196A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING α-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME
08/11/2005WO2005073163A1 A process for the preparation of [2-(2,6-dichloro anilino) phenyl] acetoxy acetic acid
08/11/2005WO2005054174A3 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex
08/11/2005WO2005051888A3 Diphenylamine derivatives
08/11/2005US20050176689 For therapy, useful as regulators of cell proliferation and differentiation, and particularly as agents for treating skin-related diseases
08/11/2005US20050176648 oligopeptide including enantiomers, stereoisomers and tautomers, used as hepatitis c protease enzyme inhibitors for prophylaxis or prevention of viral diseases
08/10/2005EP1561744A2 Amine derivatives, process for producing the same and their use as antimycotic agent
08/10/2005EP1325012A4 A composition and method for preparing amino acid chelates free of interfering ions
08/10/2005EP1157002B1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
08/10/2005EP1068306B1 Pentaerythritol lipid derivatives
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653036A Amino acids with affinity for the alpha-2-delta-protein
08/10/2005CN1653035A Method for producing 2-(4-N, N-dialkylamino-2-hydroxybenzol)benzoates
08/10/2005CN1653032A Substituted phenylalkanoic acid derivatives and use thereof
08/10/2005CN1653025A NK1 antagonists
08/10/2005CN1652759A Small molecule entry inhibitors
08/10/2005CN1651402A Propionyl-L-carnitine synthesis technology and detection method of related substance and its content
08/10/2005CN1651401A Extraction technology of gamma amino butyric acid in folium mori
08/10/2005CN1651400A Synthesis method of L-n-valaine
08/10/2005CN1214018C Morpholinones as light stabilizers
08/10/2005CN1214008C Therapeutic biaryl derivatives
08/10/2005CN1214000C Crystallizing process of glutaminic acid monohydrate monosodium crystal
08/10/2005CN1213999C Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
08/10/2005CN1213997C Method for making 2-(N-phenylamino) benzoic acids derivatives
08/09/2005US6927303 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
08/09/2005CA2164690C Method for safening herbicides in cereal crops using 5-aryloxy-1, 2-(disubstituted)benzene compounds
08/04/2005WO2005070869A1 Selective hydrogenation of nitrogen containing aromatics
08/04/2005WO2005069930A2 Asymmetric hydrogenation of alpha-amino carbonyl compounds
08/04/2005WO2005030700A3 Amino acids with affinity for the alpha2delta-protein
08/04/2005US20050171070 Stable salts of o-acetylsalicylic acid containing basic amino acids II
08/04/2005US20050171065 NAALADas, N-Acetylated-Alpha-Linked-Acidic-Dipeptidase inhibitors; 5-phosphonomethyl-1,3-benzenedicarboxylic Acid; glutamate abnormalities, anticancer, antidiabetic agent, angiogenesis inhibitor, neuropathy, pain, compulsive disorders, prostate diseases, glaucoma
08/04/2005US20050171002 Polyoxyalkylene compound and method for making
08/03/2005EP1559718A1 Combretastatin A-4 phosphate prodrug salts with nitrogen-containing compounds
08/03/2005EP1558564A2 A process for synthesis of 1-(aminomethyl)cyclohexane acetic acid hydrochloride
08/03/2005CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
08/03/2005CN1649828A Tumor imaging compounds
08/03/2005CN1649827A Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
08/03/2005CN1649822A Intergrated chemical processes for industrial utilization of seed oils
08/03/2005CN1213020C Phenylalaninol derivatives
08/02/2005US6924377 Etherifying mucochloric or mucobromic acid with an alcohol, alkylation, hydrogenation, dehydrochlorination or dehydrobromination, decyclization by reductive amination and carboxylation; 3-Aminomethyl-5-methyl-hexanoic acid
08/02/2005US6924307 Metalloproteinase inhibitor; antiarthritic agents, osteoporosis; cardiovascular disorders; antitumor agents; autoimmune diseases
08/02/2005CA2321639C Bicyclo[2.2.1]heptanes and related compounds
08/02/2005CA2254972C Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives
08/02/2005CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005WO2005068643A2 Biochemical synthesis of 6-amino caproic acid
07/28/2005WO2005026106B1 Process of hydrocyanation of unsaturated carboxylic acid derivatives
07/28/2005US20050165102 Improved bioavailability by complexing a drug such as metformin with an ionic moiety such as a fatty acid; e.g. metformin laurate; wrong claims attached to this publication
07/28/2005US20050165099 UV filters in cosmetic preparations; separating off the solvent, for example via a falling-film or thin-layer evaporator under reduced pressure, and then distilling the residue containing the product of value over a column; packaged as a melt
07/28/2005US20050164972 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
07/28/2005US20050164971 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
07/28/2005US20050164963 Components for producing amphoteric liposomes
07/28/2005US20050164869 Practical chiral zirconium catalyst
07/28/2005US20050164391 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
07/28/2005US20050163850 Administration of levodopa and carbidopa
07/28/2005US20050163849 Compositions and dosage forms for enhanced absorption of iron
07/28/2005US20050163848 complexed with transport moiety comprising a lauryl sulfate salt; complex provides an enhanced absorption of the drug in the lower gastrointestinal tract; to control seizures or neuropathic pain with once daily administration
07/28/2005US20050163841 to controllably deliver orally a drug at a substantially zero order delivery rate a during a window; improved oral absorption
07/27/2005EP1556336A1 Metal complexes of alpha amino dicarboxylic acids
07/27/2005EP1556330A2 Phenyl compounds
07/27/2005EP1556059A1 Thrombopoietin mimetics
07/27/2005EP1556029A2 Thiomolybdate analogues and uses thereof
07/27/2005CN1646480A Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
07/27/2005CN1212310C Propanol amine kind ether compound synthesized using paeonol as mother body and its derivative
07/27/2005CN1212309C Propanol amine kind ether compound synthesized using paeonol as mother body and its derivative
07/26/2005US6921835 Carbocyclic carboxy amines such as 1-aminomethyl-3,4-dimethyl-cyclopentyl acetic acid or prodrugs used as antiepileptics, antidepressants, anxiolytics, analgesics, antiinflammatory agents and for prophylaxis of neurodegenerative disorders
07/26/2005US6921774 Administering compounds such as N-(3-(5-Cyano-1-(4-fluoro-phenyl)-1,3-dihydroisobenzofuran-1-yl)-1 -propyl)glycine ethyl ester, for prophylaxis of psychological disorders
07/26/2005CA2256579C Process for the bleaching of chemical pulp
07/21/2005WO2005046878A3 Use of a derivative of aspartic acid as a collector in froth flotation processes
07/21/2005US20050159626 Norbornane based cycloaliphatic compounds containing methylene amine groups